Presenter: James E. Metz, DDS

$20.00$40.00

Description

Unlike medicine, dentistry can alter the activity of the sympathetic nervous system. Metz’s published research (High-Resolution Pulse Oximetry and Titration of a Mandibular Advancement Device for Obstructive Sleep Apnea, Frontiers in Neurology, July 15, 2019) points the way to the future of Dental Sleep Medicine and forms the basis for his presentation.

Learning Objectives:

  1. How a dentist can simply titrate a specific Mandibular Advancement Device (MAD) with a high degree of accuracy and effectiveness for all severity levels by the use of HRPO (SatScreen software and SleepSat oximeter).
  2. Emphasizing home care (100% nasal breathing with reduced volume, increased nitric oxide production, lip tape at night, control of gastroesophageal reflux disease(GERD), and left side sleeping), combined with the MAD, can increase success rates of Dental Sleep Medicine to the AHI<5 range (recognized level for CPAP success) for most all sleep apnea patients.
  3. The control of “bite change” by eliminating many of the contributing factors.
  4. Understanding the role of mucin in airway health.

Presenter: James E. Metz, DDS

Course Details

CE Hours

2.0 Hours

Subject Code

130 Electives

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

AGD-Washington

19415 International Blvd Ste 410
SeaTac, WA 98188-5366
AGD Provider ID # 219331
(206) 212-4969
www.washingtonagd.org

Nationally Approved From 6/1/2018 – 5/31/2024
Approved PACE Program Provider FAGD/MAGD Credit Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement.
 

The Washington AGD Continuing Dental Education Committee gratefully acknowledges corporate partners of our programs for their generous support. CE program providers and instructors will disclose to participants any monetary or other special interest the program provider may have with any corporate partners products they are discussing in CE activities. Disclosure will be made in publicity materials and at the beginning of the presentation itself in accordance with our PACE Commerical Support Guidelines.